Efficacy of SGLT2 Inhibitors in Adults With Sepsis

Recruiting now · Not applicable · Has a placebo group

Conditions studied: Sepsis, Inflammation, SGLT2 Inhibitors, Critically Ill, Organ Dysfunction Syndrome

In brief

Goal of this clinical trial is to examine the safety and efficacy of SGLT2 inhibitors on the clinical outcomes in patients with sepsis. Main study outcomes are as follows: (i) Primary objective is to examine the efficacy and safety of SGLT2 inhibitors on clinical outcomes in patients with sepsis. (ii) Secondary objective is to examine the effect of SGLT2 inhibitors on inflammatory markers in patients with sepsis.

Key facts

Study ID
NCT06473844
Run by
Hospital Authority, Hong Kong
People needed
60
Starts
2025-03-05
Expected to finish
2027-02-28
Last updated by the study team
2025-03-19

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.